s 12363 has been researched along with hoe 33342 in 1 studies
| Studies (s 12363) | Trials (s 12363) | Recent Studies (post-2010) (s 12363) | Studies (hoe 33342) | Trials (hoe 33342) | Recent Studies (post-2010) (hoe 33342) |
|---|---|---|---|---|---|
| 18 | 4 | 0 | 1,270 | 0 | 245 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anstett, M; Combe-Perez, V; Leonce, S; Pierre, A | 1 |
1 other study(ies) available for s 12363 and hoe 33342
| Article | Year |
|---|---|
Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
Topics: Acridine Orange; Animals; Benzimidazoles; Cell Cycle; Chromatin; Flow Cytometry; Leukemia L1210; Mice; Mitosis; Thymidine; Tumor Cells, Cultured; Vinblastine; Vinca Alkaloids; Vincristine; Vindesine | 1990 |